Ignite Creation Date:
2024-05-06 @ 9:35 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03010735
Status:
COMPLETED
Last Update Posted:
2020-10-22
First Post:
2016-12-28
Brief Title:
Effects of Probiotics on the Patients With End Stage Renal Disease ESRD
Sponsor:
China Agricultural University
Organization:
China Agricultural University
Study Overview
Official Title:
Effects of Probiotics on Metabolism of Uremic Toxin in Patients With End Stage Renal Disease ESRD
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the effects of oral administration of probiotics on the metabolism of uremic toxins in the patients with End Stage Renal Disease ESRD One hundred and fifty hemodialysis patients are recruited and a Double Blind Randomized Parallel Controlled Trial was performedThe microbiota-derived uremic toxin such as indoxyl sulfate and p-cresol sulfate are measured as Primary Outcome The Fecal microbiome fecal metabolites blood metabolites defecation Gastrointestinal Symptoms The Kidney Disease Quality of Life and The Occurrence of Cardiovascular Event are also assessed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None